Drug-related mortality and fatal overdose risk: pilot cohort study of heroin users recruited from specialist drug treatment sites in London.
about
QTc interval screening for cardiac risk in methadone treatment of opioid dependenceECG screening for preventing long QTc-related cardiac morbidity/mortality in methadone treated opioid addictsBurden of disease and cost of chronic hepatitis C infection in CanadaTrends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007Mortality among methadone maintenance clients in China: a six-year cohort studyAgent-Based Model Forecasts Aging of the Population of People Who Inject Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C InfectionsOverdose deaths following previous non-fatal heroin overdose: record linkage of ambulance attendance and death registry data.Problem drug use the public health imperative: what some of the literature saysModelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality.Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research DatabaseGender differences in health related quality of life of young heroin users.The impact of drug use patterns on mortality among polysubstance users in a Canadian setting: a prospective cohort studyExamining non-AIDS mortality among people who inject drugs.Ongoing impact of HIV infection on mortality among people who inject drugs despite free antiretroviral therapy.Factors associated with premature mortality among young injection drug users in VancouverAntiretroviral HIV treatment and care for injecting drug users: an evidence-based overviewYears of potential life lost among heroin addicts 33 years after treatment.Community-based interventions to prevent fatal overdose from illegal drugs: a systematic review protocolTake-home naloxone to reduce heroin death.Mortality among people who inject drugs: a systematic review and meta-analysis.Hepatitis C virus infection in Argentina: Burden of chronic disease.Psychosocial and contextual correlates of opioid overdose risk among drug users in St. Petersburg, RussiaRacial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy.Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia.Factors influencing mortality among alcohol and drug treatment clients in Victoria, Australia: the role of demographic and substance use characteristics.Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment.Is elimination of HCV possible in a country with low diagnostic rate and moderate HCV prevalence?: The case of Greece.The present and future disease burden of hepatitis C virus infections with today's treatment paradigm - volume 3.The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2.Fatal and non-fatal overdose after narcology hospital discharge among Russians living with HIV/AIDS who inject drugs.The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.Mortality risk for cocaine abusers in relation to heroin use: a follow-up study.Risk of mortality on and off methadone substitution treatment in primary care: a national cohort study.Drastic elevations in mortality among female injection drug users in a Canadian setting.Combined effects of law enforcement and substitution treatment on heroin mortality.Mortality among opiate users: opioid maintenance therapy, age and causes of death.The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4.Mortality risk among new onset injection drug users.Manners of Death in Drug-Related Fatalities in Florida.Cause and motivation in cases of non-fatal drug overdoses in opiate addicts.
P2860
Q24201880-60990EDE-A71D-4C06-ABEC-F32EC44A773DQ24235379-7E314CF3-FD00-4C4E-9646-083115A55BEDQ26849591-00BE7484-DAD7-4973-A38B-BA0738A659E9Q28533642-90DD8664-963F-4DA8-B74F-8DD4D639462DQ28537626-58C44073-5124-4593-B6EB-6C8E5D608D7CQ28548643-BADA6BDB-8B51-4343-B208-BB867F8E16AFQ33481195-5F56BD4C-8A78-4D62-AF2F-32F549544C45Q33587188-E0516F20-1193-41BD-8E68-BE7DF3649831Q34028307-A8657391-E61B-4EDE-B312-148EDC1E9A2EQ34246166-8C8FAFF7-F078-4600-A08E-DCBD9D99E7B9Q34461495-C6337EAF-A036-469D-8EEC-0AEE6D87E5FBQ34582040-F5FCDF52-08EC-4FB8-BC70-DB2760DAFF95Q34585154-B6EC5677-9A62-4FB9-98BA-73961CF4D887Q34735099-1D72F431-D0E1-4D17-96DB-F40206993D3EQ35585416-DDD048D7-A188-4339-8988-455BF82BE1E3Q36063045-E80868AB-86C2-4621-9604-4E7DEF2E2CA8Q36087748-4EEE25D8-DFD9-4D42-98E5-9C4484B5C3B6Q36258594-43E259F0-2EC9-4ECB-A6BD-8246878B54EDQ36347921-42C4334E-7565-4C04-8BAE-47F2D04DE3C9Q36706977-FCBA7EF3-353D-4D4A-8CF8-58C506015D6FQ36924982-34D2AC1B-3D57-494D-8C7C-DF0B4C1A69DEQ37299196-9DF72072-A176-4797-A79C-FD08BB724DCBQ37439827-1310EC6C-9333-43DA-89E2-484CD5B11A78Q38233245-0BE79968-A669-47DA-BC04-2C978F4F560DQ38450775-6ACE0FC9-7675-4F7A-A944-A1CBACF0BF90Q38838703-AB3D37D1-5F70-4E80-A13D-DB7CACC1E60DQ38842781-90B5B72A-3B5A-403F-8FF9-01E56AF9F9CBQ38948615-9BD23465-6C57-4282-939A-3663368C4FBEQ39064153-5040FBA0-44E1-4018-8213-B72B243FEC75Q39138996-41E0719C-C51A-43D0-9703-1BCE60983ED0Q39213684-B6D88F13-3257-44A7-83D3-AFCF5ADBC9FBQ39431848-F5650457-10EA-441F-BC08-207E0391A70BQ40669150-84F0671B-21CD-4F92-BF6B-2756A288A59DQ42675244-564A3F2C-7E1D-44F0-90BB-24463A622885Q42871670-743CD812-4F16-44F6-95BB-CEE2F8522E3DQ44342552-AFD483B3-0154-4199-B9DB-9D32B8F8361EQ45325257-82BB3E13-0ABD-4D8A-8C96-5F876A84A4AFQ46921682-F6A10C9B-EE59-4357-9C85-96C8E40DD7D1Q48056984-08E903D7-8D93-49A5-BF96-65CAAD9A83FFQ48445029-39219CD9-AEFA-477B-8D29-4B0497F28505
P2860
Drug-related mortality and fatal overdose risk: pilot cohort study of heroin users recruited from specialist drug treatment sites in London.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Drug-related mortality and fat ...... rug treatment sites in London.
@ast
Drug-related mortality and fat ...... rug treatment sites in London.
@en
type
label
Drug-related mortality and fat ...... rug treatment sites in London.
@ast
Drug-related mortality and fat ...... rug treatment sites in London.
@en
prefLabel
Drug-related mortality and fat ...... rug treatment sites in London.
@ast
Drug-related mortality and fat ...... rug treatment sites in London.
@en
P2093
P2860
P356
P1476
Drug-related mortality and fat ...... rug treatment sites in London.
@en
P2093
Cleone Rooney
Gerry Stimson
Matthew Hickman
Peter Madden
Richard Ashcroft
Zenobia Carnwath
P2860
P2888
P304
P356
10.1093/JURBAN/JTG030
P577
2003-06-01T00:00:00Z
P5875
P6179
1048968306